4538.T Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 09:15):

Stats
Šios dienos apimtis	10 100.00
Vidutinė apimtis	21 706.00
Rinkos kapitalizacija	18.92B
EPS	¥0 ( 2024-02-12 )
Kita pelno data	( ¥0 ) 2024-05-08
Last Dividend	¥40.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	14.45
ATR14	¥4.29 (0.19%)

Fuso Pharmaceutical Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Fuso Pharmaceutical Finansinės ataskaitos

Annual	2022
Pajamos:	¥51.02B
Bruto pelnas:	¥13.74B (26.94 %)
EPS:	¥182.99

FY	2022
Pajamos:	¥51.02B
Bruto pelnas:	¥13.74B (26.94 %)
EPS:	¥182.99

FY	2022
Pajamos:	¥49.63B
Bruto pelnas:	¥13.40B (26.99 %)
EPS:	¥169.09

FY	2021
Pajamos:	¥49.25B
Bruto pelnas:	¥14.11B (28.65 %)
EPS:	¥183.18

Financial Reports:

No articles found.

Fuso Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥30.00 (N/A)	¥0 (N/A)	¥40.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Fuso Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 2.71 - Decrease likely (45.90%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥50.00	2001-03-27
Last Dividend	¥40.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	46	--
Total Paid Out	¥1 530.00	--
Avg. Dividend % Per Year	0.00%	--
Score	3.52	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	2.71
Div. Directional Score	6.87	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.26 %

Dividend Stability

0.10 Bad

Dividend Score

3.52

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6349.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
5204.T	Ex Dividend Knight	2024-03-18	Annually	0.00%
4308.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
3480.T	Ex Dividend Knight	2023-10-30	Annually	0.00%
2689.T	Ex Dividend Junior	2024-06-27	Annually	0.00%
9601.T	Ex Dividend Junior	2024-02-28	Sporadic	0.00%
8142.T	Ex Dividend Knight	2024-01-30	Annually	0.00%
7506.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
6727.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
6071.T	Ex Dividend Knight	2023-12-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0245	1.500	9.51	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0172	1.200	9.43	10.00	[0 - 0.3]
returnOnEquityTTM	0.0373	1.500	-0.697	-1.045	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.517	0.800	7.41	5.93	[1 - 3]
quickRatioTTM	1.056	0.800	8.49	6.80	[0.8 - 2.5]
cashRatioTTM	0.214	1.500	9.92	10.00	[0.2 - 2]
debtRatioTTM	0.184	-1.500	6.94	-10.00	[0 - 0.6]
interestCoverageTTM	12.47	1.000	6.49	6.49	[3 - 30]
operatingCashFlowPerShareTTM	516.19	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	516.19	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.396	-1.500	8.42	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.253	1.000	9.12	9.12	[0.2 - 0.8]
operatingProfitMarginTTM	0.0381	1.000	-1.237	-1.237	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.306	1.000	9.41	9.41	[0.2 - 2]
assetTurnoverTTM	0.703	0.800	8.65	6.92	[0.5 - 2]
Total Score				11.03

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	14.14	1.000	8.67	0	[1 - 100]
returnOnEquityTTM	0.0373	2.50	-0.448	-1.045	[0.1 - 1.5]
freeCashFlowPerShareTTM	516.19	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	3.13	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	516.19	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.836	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0800	1.000	-0.501	0	[0.1 - 0.5]
Total Score				2.71

Fuso Pharmaceutical

Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. The company offers ethical drugs, such as injectables and artificial kidney dialysates; and medical machinery and equipment. It also rents real estate properties. The company was founded in 1937 and is headquartered in Osaka, Japan.